The biopharmaceutical CMO Market has witnessed rapid growth in recent years. The size increased from $24.81 billion in 2024 to $28.09 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth during this period is attributable to increasing demand for biopharmaceuticals, globalization, rising healthcare expenditure, regulatory support, and increased research funding.
The market is poised to expand further, reaching $48.04 billion by 2029 at a CAGR of 14.4%. The predicted growth is driven by factors such as rising telehealth and remote trials, global health initiatives, disposable income growth, and increased awareness of global health initiatives. The forecast period will also see major trends such as advanced therapies dominance, digitalization and industry 4.0, continuous manufacturing, and sustainability and green practices.
Get Your Free Sample of The Global Biopharmaceutical CMO Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7771&type=smp
What’s Driving The Growth Of The Biopharmaceutical CMO Market?
The growth of the biopharmaceutical CMO market is positively influenced by the increase in geriatric population. Individuals above the age of 60-years are more susceptible to diseases such as heart attack, stroke, and coronary heart disease.
The rise in the geriatric population is attributed to the advances in healthcare, decline in birth rates, and the aging baby boomer generation. This aging demographic is driving the demand for biopharmaceutical therapies to combat age-related conditions like cardiovascular disorders.
Biopharmaceutical CMOs are playing a critical role in this context by providing specialized manufacturing capabilities for complex biologics and personalized medicines tailored to address these needs. For instance, the US-based Population Reference Bureau projected in January 2024 that the number of Americans aged 65 and older would increase from 58 million in 2022 to 82 million by 2050. The growth of the geriatric population is thus fueling the biopharmaceutical CMO market.
What Are The Major Segments In The Biopharmaceutical CMO Market?
1) By Product: Biologics, Biosimilars
2) By Source: Mammalian, Non-Mammalian
3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging
Quick, Order your report for swift delivery:
https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report
Who Are The Major Players In The Biopharmaceutical CMO Market?
The major players in the biopharmaceutical CMO market include Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Synlogic, Inc., MedImmune (AstraZeneca), BioLife Sciences, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, AltheaDx, Daxor Corporation, Genomatica, Inc., Astellas Pharma, Juno Therapeutics (Celgene), Medpace, Celerion, Evonik Industries AG.
What Are The Emerging Trends In The Biopharmaceutical CMO Market?
One key trend gaining traction in the biopharmaceutical CMO market is technological advancement. Companies are adopting and developing new technologies for improvement using IoT.
For instance, M2Cloud, a Korea-based bio-cold chain technology company, developed an IoT-based LTE monitoring system for biopharmaceutical monitoring in collaboration with Thales, a France-based company specializing in IoT communication modules. It is beneficial in real-time monitoring of freezers, refrigerated warehouses, delivery boxes, and more, providing real-time temperature and position information remotely.
Which Region Leads The Biopharmaceutical CMO Market, And Which Is Expected To Grow The Fastest?
In 2024, North America was the largest region in the biopharmaceutical CMO market, while the Asia-Pacific region is projected to be the fastest-growing during the forecast period. The report covers regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Exactly Does The Biopharmaceutical CMO Market Report Offer?
The Biopharmaceutical CMO Market assists in lowering overall operational risk and time to market by providing manufacturing services, with the capacity to produce small quantities for preclinical research and development and more significant numbers needed for clinical trials and commercialization.
The Biopharmaceutical CMO Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Unlock valuable market insights by purchasing the exclusive report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7771
Contact Information:
About The Business Research Company
With over 15000+ reports spanning across 27 industries and 60+ geographies, The Business Research Company has established a reputation for offering comprehensive, data-rich research and insights. With 1,500,000 datasets, the combined strength of detailed secondary research, and unique market insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform that delivers comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
